Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Sales (2021)

Cullinan Therapeutics (CGEM) has 1 years of Return on Sales data on record, last reported at 3.56% in Q4 2021.

  • For Q4 2021, Return on Sales changed N/A year-over-year to 3.56%; the TTM value through Dec 2021 reached 3.56%, changed N/A, while the annual FY2021 figure was 3.56%, N/A changed from the prior year.
  • Return on Sales reached 3.56% in Q4 2021 per CGEM's latest filing, down from 3.29% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.07% in Q1 2021 and bottomed at 3.56% in Q4 2021.